Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Completed · Phase 2
Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: Progesterone can cause the growth of ovarian epithelial cancer , primary peritoneal cancer, or fallopian tube cancer. Hormone therapy using mifepristone may fight ovarian epithelial cancer and primary peritoneal cancer by lowering the amount of progesterone the body makes. PURPOSE: This phase II trial is studying the side effects and how well mifepristone works in treating patients with recurrent or persistent ovarian epithelial cancer, primary peritoneal cancer, or fallopian tube cancer.
Key facts
- Study ID
- NCT00459290
- Run by
- Gynecologic Oncology Group
- People needed
- 24
- Starts
- 2007-05-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2018-07-18
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Medical Center - Los Angeles — Los Angeles, California, United States
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center — Hartford, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus — New Britain, Connecticut, United States
- Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
- Woman's Hospital — Baton Rouge, Louisiana, United States
- Maine Medical Center - Bramhall Campus — Portland, Maine, United States
- Regional Cancer Center at Singing River Hospital — Pascagoula, Mississippi, United States
- Freeman Cancer Institute at Freeman Health System — Joplin, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South — Springfield, Missouri, United States
- Methodist Estabrook Cancer Center — Omaha, Nebraska, United States
- Cancer Institute of New Jersey at Cooper - Voorhees — Voorhees Township, New Jersey, United States
- Case Comprehensive Cancer Center — Cleveland, Ohio, United States
- Riverside Methodist Hospital Cancer Care — Columbus, Ohio, United States
- Lake/University Ireland Cancer Center — Mentor, Ohio, United States
- Oklahoma University Cancer Institute — Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital — Abington, Pennsylvania, United States
- Bryn Mawr Hospital — Bryn Mawr, Pennsylvania, United States
- Cancer Center of Paoli Memorial Hospital — Paoli, Pennsylvania, United States
- Lankenau Cancer Center at Lankenau Hospital — Wynnewood, Pennsylvania, United States
- Women and Infants Hospital of Rhode Island — Providence, Rhode Island, United States
- University of Texas Medical Branch — Galveston, Texas, United States
- Marshfield Clinic - Marshfield Center — Marshfield, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.